Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest Finland
Hanna Heloterä, Anna-Mari Viita, Juha Laine · 2024
Read Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest Finland by Hanna Heloterä, Anna-Mari Viita, Juha Laine (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11640760.txt.
Description
Hanna Heloterä, Anna-Mari Viita, and Juha Laine published a 2024 study of how injection treatments for eye disease changed workloads in southwest Finland. Drugs that block a growth signal are now injected into the eye for several conditions, including age-related macular degeneration and diabetic swelling. The team used hospital registry data from 2015 to 2022 to track patient counts and injection numbers.
The number of treated patients grew by about 200 percent between 2015 and 2021. Injection counts rose too, though the yearly growth slowed from about 24 percent to about 7 percent by the end of the period. The authors argue that registry data can guide staffing and planning for eye departments. They also warn that registries have limits and gaps that planners must keep in mind.
Catalog record
| CREATOR | Hanna Heloterä, Anna-Mari Viita, Juha Laine |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |